Praeveo detects Phase III delay patterns 4 weeks before they hit your steering committee.
Your Clinical Research Associates are stretched across multiple trials. Capacity conflicts surface too late — when enrollment targets are already missed.
Site-by-site enrollment data lives in spreadsheets and CTMS exports. Deviation from plan is invisible until the quarterly review reveals a 6-week gap.
Protocol amendments, IB updates, and regulatory submissions pile up. Each delayed document creates a cascading effect on your regulatory timeline.
Detects when CRAs are overallocated across parallel trials before capacity gaps hit enrollment.
Tracks site-level enrollment velocity against targets and flags deviations early.
Monitors the rate and impact of protocol amendments on your overall trial timeline.
Tracks regulatory document queues and flags growing backlogs before they delay submissions.
Real-time trial recruitment rates to benchmark your enrollment pace against industry averages.
Approval cycle tracking to model regulatory risk and anticipate submission bottlenecks.
Competitor trial landscape data to understand site competition and enrollment pressure.
Site accessibility impact modeling to predict weather-driven disruptions at trial locations.
"What if enrollment drops 30% at 3 sites?"
"We caught a Phase III enrollment gap 5 weeks before it would have hit our steering committee. Praeveo paid for itself in the first quarter."
30 seconds — and we'll get back to you within 24 hours. No sales pitch, just an honest conversation about your challenges.
Book a conversation →